Simon Pernot

5.9k total citations · 2 hit papers
99 papers, 3.5k citations indexed

About

Simon Pernot is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Simon Pernot has authored 99 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Oncology, 41 papers in Pulmonary and Respiratory Medicine and 25 papers in Surgery. Recurrent topics in Simon Pernot's work include Colorectal Cancer Treatments and Studies (32 papers), Gastric Cancer Management and Outcomes (20 papers) and Cancer Immunotherapy and Biomarkers (17 papers). Simon Pernot is often cited by papers focused on Colorectal Cancer Treatments and Studies (32 papers), Gastric Cancer Management and Outcomes (20 papers) and Cancer Immunotherapy and Biomarkers (17 papers). Simon Pernot collaborates with scholars based in France, Italy and Spain. Simon Pernot's co-authors include Julien Taı̈eb, Magali Terme, Éric Tartour, Elie Marcheteau, Orianne Colussi, Thibault Voron, Nadine Benhamouda, Olivier Dubreuil, Anne‐Laure Pointet and Aziz Zaanan and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Simon Pernot

94 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors

2015 883 citations Thibault Voron, Orianne Colussi et al. profile →
VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer

2012 522 citations Magali Terme, Simon Pernot et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simon Pernot France	25	2.2k	1.1k	938	759	609	99	3.5k
Ravit Geva Israel	33	4.1k 1.9×	1.6k 1.5×	1.2k 1.3×	822 1.1×	827 1.4×	134	5.3k
John H. Strickler United States	29	2.1k 1.0×	962 0.9×	399 0.4×	941 1.2×	708 1.2×	216	3.4k
Kun He United States	27	2.0k 0.9×	1.3k 1.2×	578 0.6×	835 1.1×	475 0.8×	53	3.2k
Jifang Gong China	29	1.7k 0.8×	928 0.9×	381 0.4×	785 1.0×	603 1.0×	147	2.9k
Hisato Kawakami Japan	32	2.7k 1.2×	1.6k 1.5×	266 0.3×	834 1.1×	508 0.8×	179	3.8k
Changping Wu China	25	1.3k 0.6×	508 0.5×	619 0.7×	673 0.9×	599 1.0×	58	2.4k
P. Murawa Poland	16	3.0k 1.4×	1.2k 1.1×	377 0.4×	890 1.2×	1.1k 1.8×	47	4.1k
Austin G. Duffy United States	27	1.5k 0.7×	749 0.7×	580 0.6×	512 0.7×	472 0.8×	87	2.8k
Patrick M. Forde United States	40	4.0k 1.8×	2.7k 2.6×	1.1k 1.2×	934 1.2×	645 1.1×	186	5.7k
Petr Kavan Canada	29	1.5k 0.7×	1.1k 1.1×	331 0.4×	1.0k 1.3×	876 1.4×	141	4.4k

Countries citing papers authored by Simon Pernot

Since Specialization

Citations

This map shows the geographic impact of Simon Pernot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Pernot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Pernot more than expected).

Fields of papers citing papers by Simon Pernot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Pernot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Pernot. The network helps show where Simon Pernot may publish in the future.

Co-authorship network of co-authors of Simon Pernot

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Pernot. A scholar is included among the top collaborators of Simon Pernot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Pernot. Simon Pernot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gerovska, Daniela, Marcos J. Araúzo‐Bravo, Géraldine Siegfried, et al.. (2025). Inhibition of PCSK9 Attenuates Liver Endothelial Cell Activation Induced by Colorectal Cancer Stem Cells During Liver Metastasis. Cancers. 17(12). 1977–1977.

Taı̈eb, Julien, Margherita Ambrosini, Sara Lonardi, et al.. (2025). Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. 13(1). e010424–e010424. 2 indexed citations

Dupré, Aurélien, Pascal Artru, Antoine Drouillard, et al.. (2024). Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study. Digestive and Liver Disease. 56(9). 1605–1613.

Borg, Christophe, V. Vendrely, Thierry André, et al.. (2023). 651P DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: A multicenter propensity score matching study. Annals of Oncology. 34. S456–S457. 1 indexed citations

Gallois, Claire, Édouard Auclin, Elisabeth Bergen, et al.. (2023). 625P Efficacy and safety of the combination of encorafenib and cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: An AGEO real-world multicentre study. Annals of Oncology. 34. S446–S446. 4 indexed citations

Pernot, Simon, Olivier Pellerin, Laurent Mineur, et al.. (2022). Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2 +/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49. Digestive and Liver Disease. 54(3). 324–330. 6 indexed citations

Hautefeuille, Vincent, Louis de Mestier, Clélia Coutzac, et al.. (2022). Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study. International Journal of Cancer. 152(9). 1894–1902. 2 indexed citations

Béchade, Dominique, Carine Bellera, Pippa McKelvie‐Sebileau, et al.. (2022). Diagnostic accuracy and clinical impact of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in Positron Emission Tomography - Computed Tomography (PET-CT)-positive mediastinal lymphadenopathies in patients with thoracic or extra-thoracic malignancies. Clinics and Research in Hepatology and Gastroenterology. 46(5). 101912–101912. 2 indexed citations

Hautefeuille, Vincent, Édouard Auclin, Astrid Lièvre, et al.. (2022). Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study. British Journal of Cancer. 126(10). 1394–1400. 5 indexed citations

10.

Araúzo‐Bravo, Marcos J., Zongsheng He, Álvaro González, et al.. (2022). Role of Furin in Colon Cancer Stem Cells Malignant Phenotype and Expression of LGR5 and NANOG in KRAS and BRAF-Mutated Colon Tumors. Cancers. 14(5). 1195–1195. 8 indexed citations

11.

Cousin, Sophie, Coralie Cantarel, Jean‐Philippe Guégan, et al.. (2021). Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial. Clinical Cancer Research. 27(8). 2139–2147. 95 indexed citations

12.

Hirsch, Laure, David Malka, Simon Pernot, et al.. (2021). Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer Patients. Cancers. 13(21). 5562–5562. 10 indexed citations

13.

Pernot, Simon, Olivier Pellerin, Pascal Artru, et al.. (2020). Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study. British Journal of Cancer. 123(4). 518–524. 19 indexed citations

14.

Gallois, Claire, Pascal Artru, Astrid Lièvre, et al.. (2019). Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study. European Journal of Cancer. 119. 35–43. 28 indexed citations

15.

Ursino, Moreno, Peter F. Thall, Bruno Landi, et al.. (2019). Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer data. Statistical Methods in Medical Research. 29(2). 541–567. 7 indexed citations

16.

Pernot, Simon, Olivier Dubreuil, Thomas Aparicio, et al.. (2018). Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study. British Journal of Cancer. 119(4). 424–428. 24 indexed citations

17.

Coutzac, Clélia, Simon Pernot, Nathalie Chaput, & Aziz Zaanan. (2018). Immunotherapy in advanced gastric cancer, is it the future?. Critical Reviews in Oncology/Hematology. 133. 25–32. 98 indexed citations

18.

Pernot, Simon, Pauline Boucheron, Hélène Péré, et al.. (2018). Comparison of anal cancer screening strategies including standard anoscopy, anal cytology, and HPV genotyping in HIV-positive men who have sex with men. British Journal of Cancer. 119(3). 381–386. 32 indexed citations

19.

Pernot, Simon, G. Amouyal, Marc Sapoval, et al.. (2017). 5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases. Clinics and Research in Hepatology and Gastroenterology. 42(3). 255–260. 6 indexed citations

20.

Terme, Magali, Simon Pernot, Elie Marcheteau, et al.. (2012). VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer. Cancer Research. 73(2). 539–549. 522 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact